ArticleInternational journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group2025
The efficacy of hyperthermia-based multimodal therapy is dependent on gatekeeper protein, BID.
Sarah Helmueller et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it